Literature DB >> 3024881

Immunological studies on adult T cell leukaemia virus (ATLV) carriers.

Y Morishima, K Ohya, T Morishima, K Nishikawa, T Fukuda.   

Abstract

Adult T cell leukaemia associated antibody (ATLA-Ab) positive people who were considered to be adult T cell leukaemia virus (ATLV) carriers were found in 0.75% of the adult population in the non-endemic area of Nagoya, Japan. Immunological studies on these people revealed that T lymphocyte subpopulations, as defined by nine monoclonal antibodies reactive to T lymphocyte surface antigens including T cell activation antigen, showed no differences between ATLA-Ab positive and ATLA-Ab negative individuals. Only a slightly higher percentage of Ia positive T lymphocytes was found in ATLA-Ab positive persons. Furthermore, the serum IgG level and the antibody titre of cytomegalovirus were significantly increased in ATLA-Ab positive individuals, while serum IgA, IgM level and the antibody titre of herpes simplex virus and mumps virus, showed no differences in both groups. This data suggests the possibility that ATLV carriers have some mild immunological abnormalities.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3024881      PMCID: PMC1542445     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  24 in total

1.  Local T cell subsets in mumps meningitis.

Authors:  H Nagai; T Morishima; Y Morishima; S Isomura; S Suzuki
Journal:  Arch Dis Child       Date:  1983-11       Impact factor: 3.791

2.  Antibodies to adult T-cell leukemia-virus-associated antigen (ATLA) in sera from patients with ATL and controls in Japan: a nation-wide sero-epidemiologic study.

Authors:  Y Hinuma; H Komoda; T Chosa; T Kondo; M Kohakura; T Takenaka; M Kikuchi; M Ichimaru; K Yunoki; I Sato; R Matsuo; Y Takiuchi; H Uchino; M Hanaoka
Journal:  Int J Cancer       Date:  1982-06-15       Impact factor: 7.396

3.  Functionally different T lymphocyte subpopulations determined by their sensitivity to complement-dependent cell lysis with the monoclonal antibody 4A.

Authors:  Y Morishima; M Kobayashi; S Y Yang; N H Collins; M K Hoffmann; B Dupont
Journal:  J Immunol       Date:  1982-09       Impact factor: 5.422

4.  Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease.

Authors:  M Yoshida; I Miyoshi; Y Hinuma
Journal:  Proc Natl Acad Sci U S A       Date:  1982-03       Impact factor: 11.205

Review 5.  Nonbacterial pneumonia after allogeneic marrow transplantation: a review of ten years' experience.

Authors:  J D Meyers; N Flournoy; E D Thomas
Journal:  Rev Infect Dis       Date:  1982 Nov-Dec

6.  Unique cell lines harbouring both Epstein-Barr virus and adult T-cell leukaemia virus, established from leukaemia patients.

Authors:  N Yamamoto; T Matsumoto; Y Koyanagi; Y Tanaka; Y Hinuma
Journal:  Nature       Date:  1982-09-23       Impact factor: 49.962

7.  Healthy carriers of a human retrovirus, adult T-cell leukemia virus (ATLV): demonstration by clonal culture of ATLV-carrying T cells from peripheral blood.

Authors:  Y I Gotoh; K Sugamura; Y Hinuma
Journal:  Proc Natl Acad Sci U S A       Date:  1982-08       Impact factor: 11.205

8.  The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus.

Authors:  A G Dalgleish; P C Beverley; P R Clapham; D H Crawford; M F Greaves; R A Weiss
Journal:  Nature       Date:  1984 Dec 20-1985 Jan 2       Impact factor: 49.962

9.  Abnormalities of B-cell activation and immunoregulation in patients with the acquired immunodeficiency syndrome.

Authors:  H C Lane; H Masur; L C Edgar; G Whalen; A H Rook; A S Fauci
Journal:  N Engl J Med       Date:  1983-08-25       Impact factor: 91.245

10.  Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma.

Authors:  B J Poiesz; F W Ruscetti; A F Gazdar; P A Bunn; J D Minna; R C Gallo
Journal:  Proc Natl Acad Sci U S A       Date:  1980-12       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.